IL1B and age-related macular degeneration: A more recent investigation by Sekar et al. on transgenic mice, proposed the pyroptotic pore-protein gasdermin D as a key-player in the escalation of retinal inflammation via the release of IL-1β, therefore indicating this pore-protein a promising therapeutic target in AMD [202].